Riaz Bandali has been named president, Early Stage Development at PharmaNet. Mr. Bandali will be responsible for the leadership of the company’s early stage clinical development business, including Phase I clinics and bioanalytical laboratories. He will be based at the company’s facility in Montreal, Canada.

“I am very pleased to welcome Riaz to PharmaNet,” said Jeffrey P. McMullen, PharmaNet’s chief executive officer. “His strategic approach and industry experience will enhance the positioning of our early stage business to the changing dynamics in the marketplace.”

Mr. Bandali joins PharmaNet from AB Sciex and Molecular Devices as senior vice-president, Strategy and Business Development. He has more than 15 years of senior management and operations leadership experience in the clinical research and life sciences industries.